CIK 0001628171 · Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472029180
- Phone
- 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,328,124
- in 21 filings, $85.3M under 10b5-1 plans
Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-25 | Mancini Anthony See Remarks | Sale 10b5-1 | −400 | $97.21 | $39K | 54,400 |
| 2026-03-25 | Mancini Anthony See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37,450 | 112,350 | ||
| 2026-03-19 | Cislini Jeff General Counsel | Sale 10b5-1 | −1,163 | $97.44 | $113K | 58,518 |
| 2026-03-17 | Wei Lin Chief Medical Officer | Sale 10b5-1 | −2,073 | $99.48 | $206K | 101,366 |
| 2026-03-17 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −4,302 | $99.48 | $428K | 295,398 |
| 2026-03-17 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −12,871 | $99.48 | $1.3M | 276,698 |
| 2026-03-17 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −4,583 | $99.48 | $456K | 157,570 |
| 2026-03-17 | Anders Jack Chief Financial Officer | Sale 10b5-1 | −2,753 | $99.48 | $274K | 125,512 |
| 2026-03-17 | Cislini Jeff General Counsel | Sale 10b5-1 | −1,795 | $99.48 | $179K | 59,681 |
| 2026-03-17 | Wang Xiaolin See Remarks | Sale 10b5-1 | −2,010 | $99.48 | $200K | 116,063 |
| 2026-03-04 | ANDERSON ELIZABETH M Director | Gift | −15,000 | 8,215 | ||
| 2026-03-04 | ANDERSON ELIZABETH M Director | Gift | +15,000 | 15,000 | ||
| 2026-03-02 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +30,000 | $4.09 | $123K | 319,569 |
| 2026-03-02 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −700 | $98.17 | $69K | 318,869 |
| 2026-03-02 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −3,500 | $99.76 | $349K | 315,369 |
| 2026-03-02 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −3,620 | $100.73 | $365K | 311,749 |
| 2026-03-02 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −21,329 | $101.60 | $2.2M | 290,420 |
| 2026-03-02 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −851 | $102.20 | $87K | 289,569 |
| 2026-03-02 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −100 | $98.31 | $10K | 67,324 |
| 2026-03-02 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −400 | $100.12 | $40K | 66,924 |
Page 11 of 18 · 352 trades